Baird, L., & Yamamoto, M. (2021). NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer. Mol Cell Biol.
Chicago Style aipamenaBaird, Liam, and Masayuki Yamamoto. "NRF2-Dependent Bioactivation of Mitomycin C As a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer." Mol Cell Biol 2021.
MLA aipamenaBaird, Liam, and Masayuki Yamamoto. "NRF2-Dependent Bioactivation of Mitomycin C As a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer." Mol Cell Biol 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.